Abstract
Introduction
In current practice, minimal invazive interventions such as percutaneous drainage and laparoscopic surgery in adjunct treatment with benzimidazoles have been gaining acceptance in treatment of hydatid cystic disease with minimal morbidity and mortality. In this prospective study, the efficacy and validity of primary medical therapy in the treatment of hydatid cystic disease has been investigated.
Patients and methods
Sixty-five patients with hepatic cystic disease were treated with albendazole alone between January 2004 and June 2007. All of the patients were administrated albendazole as 10 mg kg−1 day−1 divided into two equal doses for 6 months with ultrasonography (USG), serological tests, full-blood cell count and hepatic function tests performed in 2 months intervals in the course of treatment.
Results
Fifty of the patients were female and 15 were male with a mean age of 47.0 ± 16.9 (17–80). A total number of 106 cysts were present in 65 patients. Mean cystic diameter was 5.5 ± 3.6 (1–16). In 41 of the patients, cysts were solitary and in remaining 24 patients cysts were multiple. Mean follow-up period was 28.3 ± 8.6 (12–42) months. The overall success rate of albendazole therapy was 18 % (12/65) in the study.
Conclusion
Albendazole therapy for hepatic hydatidosis is not effective in the vast majority of patients and, therefore, should not be used as the primary therapy for patients who are surgical candidates.
Similar content being viewed by others
References
Chai J, Menghebat, Jiao W, Sun D, et al. Clinical efficacy of albendazole emulsion in treatment of 212 cases of liver cystic hydatidosis. Chin Med J 2002;115:1809–1813.
Polat C, Dervisoglu A, Hokelek M, et al. Dual treatment of albendazole in hepatic hydatidosis: New therapeutic modality in 52 cases. J Gastroenterol Hepatol 2005;20:421–425.
Aygun E, Sahin M, Odev K, et al. The management of liver hydatid cysts by percutaneous drainage. Can J Surg 2001;44:203–209.
Yetim I, Erzurumlu K, Hokelek M, et al. Results of alcohol and albendazole injections in hepatic hydatidosis: Experimental study. J Gastroenterol Hepatol 2005;20:1442–1447.
Chai J, Menghebat, Jiao W, et al. Observations on clinical efficacy of albendazole emulsion in 264 cases of hepatic cystic echinococcosis. Parasitol Int 2004;53:3–10.
Kern P. Echinococcus granulosus infection: Clinical presentation, medical treatment and outcome. Langenbecks Arch Surg 2003;388:413–420.
Kurkcuoglu IC, Eroglu A, Karaoglanoglu N, Polat P. Complications of albendazole treatment in hydatid disease of lung. Eur J Cardiothorac Surg 2002;22:649–650.
Gharbi HA, Hassine W, Brauner MW, Dupuch K. Ultrasound examination of hydatic liver. Radiology 1981;139:459–463.
Saimot AG. Medical treatment of liver hydatidosis. World J Surg 2001;25:15–20.
Dervenis C, Delis S, Avgerinos C, Madariaga J, Milicevic M. Changing concepts in the management of liver hydatid disease. J Gastrointestinal Surg 2005;9:869–877.
Menezes da Silva A. Hydatid cyst of the liver—criteria for the selection of appropriate treatment. Acta Tropica 2003;85:237–242.
Liu Y, Wang X, Wu J. Continuous long-term albendazole therapy in intraabdominal cystic echinococcosis. Chin Med J 2000;113:827–832.
Horton RJ. Albendazole in treatment of human cystic echinococcosis—12 years of experience. Acta Tropica 1997;64:79–93.
Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 1993;342:1269–1272.
Keshmiri M, Baharvahdat H, Fattahi SH, et al. Albendazole versus placebo in treatment of echinococcosis. Trans R Soc Trop Med Hyg 2001;95:190–194.
Şenyüz OF, Yeşildağ E, Celayir S. Albendazole therapy in the treatment of hydatid liver disease. Surg Today 2001;31:487–491.
Kapan M, Kapan S, Goksoy E, Perek S, Kol E. Postoperative recurrence in hepatic hydatid disease. J Gastrointestinal Surg 2006;10:734–739.
Haddad MC, Huwaijah SH, Mourad FH, Sharara AI, Al-Kutoubi AO. Adjuvant therapy in the treatment of complications after surgery for hepatic echinococcal cysts. Cardiovasc Intervent Radiol 2000;23:406–409.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kapan, S., Turhan, A.N., Kalayci, M.U. et al. Albendazole is Not Effective for Primary Treatment of Hepatic Hydatid Cysts. J Gastrointest Surg 12, 867–871 (2008). https://doi.org/10.1007/s11605-007-0458-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-007-0458-7